Terapia con cánula nasal de alto flujo en pacientes pediátricos en domicilio / High flow nasal cannula therapy in pediatric patients at home

Se realiza comentario de estudio de Israel en el cual analizan 75 pacientes pediátricos que utilizaron cánula nasal de alto flujo (CNAF) en domicilio, evaluando la seguridad, las indicaciones, los parámetros de utilización, la duración del tratamiento, los resultados clínicos y la satisfacción de los padres. Se acompaña de una revisión de la literatura del tema.

A comment is made on a study conducted in Israel analyzing 75 pediatric patients who used high-flow nasal cannula at home, evaluating safety, indications, utilization parameters, treatment duration, clinical outcomes, and parental satisfaction. It is accompanied by a literature review on the topic.

Disfunción crónica de órganos en pacientes con drepanocitosis. Parte I: manifestaciones cardiorrespiratorias / Chronic organ dysfunction in patients with sickle cell anemia. Part I: cardiorespiratory manifestations

Introducción: En la actualidad la mayoría de los pacientes con anemia falciforme alcanzan la adultez. La disfunción crónica de órganos constituye la causa primaria de muerte y representa un desafío en el manejo de estos enfermos. Objetivo: Analizar los aspectos generales de la disfunción orgánica crónica en pacientes con drepanocitosis y profundizar en las alteraciones cardiorrespiratorias. Métodos: Se realizó una revisión de los artículos publicados en los últimos diez años con el uso de los buscadores PubMed, SciELO y Google Académico. Los términos de búsqueda fueron: anemia de células falciformes, disfunción orgánica, mortalidad, hipertensión pulmonar, enfermedad pulmonar crónica, asma, apnea obstructiva del sueño. Análisis y síntesis de la información: Con el aumento de la expectativa de vida, en el manejo de los pacientes con drepanocitosis, gana en relevancia el diagnóstico precoz y el tratamiento oportuno de la disfunción crónica de órganos. Este es un proceso que comienza en la infancia, pero se hace más evidente en la etapa adulta. Las manifestaciones cardiorrespiratorias más comunes y con impacto en la morbilidad y en la mortalidad son: la hipertensión pulmonar y la enfermedad pulmonar crónica. Se describen aspectos relacionado con la prevalencia, diagnóstico, implicaciones en la evolución de los enfermos y aspectos relacionados con su tratamiento. Conclusiones: La hipertensión pulmonar y la enfermedad pulmonar crónica son frecuentes en pacientes con drepanocitosis. Ambas complicaciones tienen un impacto negativo en la evolución de estos enfermos y se asocian a aumento de la mortalidad. La detección temprana de estas afecciones, permite tomar acciones terapéuticas para disminuir sus consecuencias(AU)

Introduction: Currently, most patients with sickle cell disease reach adulthood. Chronic organ dysfunction constitutes the primary cause of death and represents a challenge in the management of these patients. Objectives: To analyze the general aspects of chronic organic dysfunction in patients with sickle cell disease and to delve into the cardiorespiratory ones. Methods: A review of the articles published in the last ten years was carried out using the PubMed, SciELO and Google Scholar search engines. The search terms were: sickle cell anemia, organ dysfunction, mortality, pulmonary hypertension, chronic lung disease, asthma, obstructive sleep apnea. Information analysis and synthesis: With the increase in life expectancy, in the management of patients with sickle cell disease, early diagnosis and timely treatment of chronic organ dysfunction gain relevance. This is a process that begins in childhood, but becomes more apparent in adulthood. The most common cardiorespiratory manifestations with an impact on morbidity and mortality are: pulmonary hypertension and chronic lung disease. Aspects related to prevalence, diagnosis, implications in the evolution of patients and aspects related to their treatment are described. Conclusions: Pulmonary hypertension and chronic lung disease are frequent in patients with sickle cell disease. Both complications have a negative impact on the evolution of these patients and are associated with increased mortality. Early detection of these conditions allows therapeutic actions to be taken to reduce their consequences(AU)

Soporte ventilatorio no invasivo como puente hacia el trasplante pulmonar: reporte de un caso / Bridging to lung transplant using noninvasive ventilatory support: a case report

El soporte ventilatorio no invasivo es una herramienta que ha demostrado mejorar la sobrevida de pacientes con falla muscular de la bomba respiratoria y el manejo de enfermedades pulmonares crónicas, incluso la ventilación no invasiva nocturna ha servido de puente hacia el trasplante pulmonar. Se presenta el caso de una adolescente de 14 años con enfermedad pulmonar crónica hipoxémica severa y falla ventilatoria secundaria, que requirió ventilación prolongada y traqueostomía en espera de trasplante pulmonar. Luego de reevaluar indemnidad de la vía aérea fue decanulada a soporte ventilatorio no invasivo, con uso alternado de mascarilla nasal nocturna y pieza bucal diurna, permitiendo descanso muscular respiratorio eficiente, y mejoría de flujo de tos con técnicas de apilamiento de aire. Este plan permitió una decanulación segura y realizar soporte continuo ventilatorio no invasivo con un programa de rehabilitación cardiorrespiratorio. Generalmente, el soporte ventilatorio no invasivo se utiliza en trastornos primarios de la bomba respiratoria. En este caso, se indicó para enfermedad pulmonar crónica hipoxémica, mostrando claros beneficios con oxigenación adecuada, buen rendimiento cardiovascular con mejor tolerancia al ejercicio y entrenamiento en el escenario de preparación al trasplante pulmonar.

Noninvasive Ventilatory Support has demonstrated to improve survival of patients with ventilatory pump muscle failure and nocturnal noninvasive ventilation is useful in chronic lung disease, even bridging to lung transplant. We present a 14 years old girl with severe hypoxemic chronic lung disease and secondary ventilatory failure, who required continuous long-term ventilation and underwent a tracheostomy waiting for lung transplant. After reevaluated the airway patency the patient was decannulated to Noninvasive Ventilation Support, alternating nocturnal nasal mask with diurnal mouth piece in order to provide efficient respiratory muscle rest, made air stacking and improved cough flow. This plan allows safe decannulation to continuous Noninvasive Ventilatory Support tailoring a rehabilitation cardiorespiratory program. Usually, Noninvasive Ventilation Support is prescribed for primary respiratory pump muscles failure, but in this case, it was applied for a hypoxemic chronic lung disease. Clear benefits were observed leading to appropriate oxygenation, good cardiovascular performance with better tolerance to exercise for training in the preparatory scenario of a lung transplant.

Case control study of risk factors and ophthalmological outcomes of very low birth weight infants with Type 1 retinopathy of prematurity

INTRODUCTION@#We evaluated the risk factors associated with Type 1 retinopathy of prematurity (ROP) in very low birth weight (VLBW) infants and compared ophthalmologic outcomes between cases with Type 1 ROP who received treatment and gestational age-matched controls with mild or no ROP not requiring treatment.@*METHODS@#This was a retrospective case-control study of VLBW infants born in National University Hospital, Singapore, from January 2001 to December 2013. 17 cases with Type 1 ROP were each matched for gestational age with controls who had either mild (below Stage 2) or no ROP. Antenatal, perinatal and postnatal variables, as well as childhood ophthalmologic outcomes, were collected from their clinical records and analysed.@*RESULTS@#The number of packed cell transfusions and highest fraction of inspired oxygen given at weeks 7-10 were found to be statistically significant on multivariate analysis (p = 0.045 and p = 0.049, respectively). None of the infants had blindness or retinal detachment, and there were no significant differences in refractive errors between the groups at 1-4 years of age. Strabismus at four years of age was more common in the group with Type 1 ROP (p = 0.023).@*CONCLUSION@#Increased episodes of blood transfusions and chronic lung disease requiring high oxygen supplementation at 7-10 weeks of life are significant risk factors associated with Type 1 ROP in VLBW infants in our study. Strabismus at four years is more common in this group of patients. This study highlights the importance of long-term ophthalmologic surveillance for these high-risk children.

An Infant with Interstitial Lung Disease

Interstitial lung disease in infants, unlike older children and adults, has diverse etiology, including infective, metabolic, autoimmune,genetic, malignant and idiopathic causes. Clinical recognition of the interstitial pattern of lung involvement is important as the etiology andmanagement is entirely different from that of recurrent or chronic lung parenchymal pathologies. We discuss the clinical and pathologicalfindings of an infant with interstitial pneumonia, who succumbed to hospital-acquired sepsis.

Bronchopulmonary dysplasia: how can we improve its outcomes? / 소아과

Bronchopulmonary dysplasia (BPD) is a chronic lung disease of preterm infants with multiple factors affected from prenatal to postnatal periods. Despite significant advances in neonatal care over almost 50 years, BPD rates have not decreased; in fact, they may have even increased. Since more preterm infants, even at periviable gestational age, survive today, different stages of lung development affect the pathogenesis of BPD. Hence, the definition of BPD has changed from “old” to “new.” In this review, we discuss the various definitions of BPD, risk factors from the prenatal to postnatal periods, management strategies by phase, and future directions for research.

Bronchopulmonary Dysplasia in Preterm Neonates in a Level III Neonatal Unit in India

Objective: To find out the incidence and associations ofbronchopulmonary dysplasia (BPD) in preterm neonates.Design: Descriptive cohort.Methods: All consecutively born neonates <33 weeks gestationrequiring oxygen or respiratory support during first 3 days of lifewere enrolled from a level III neonatal unit in Chandigarh, India.Those with malformations were excluded. Placenta wasexamined for histological chorioamnionitis in preterm rupture ofmembranes and/or preterm spontaneous onset of labour. SerumMalondialdehyde (MDA) and Superoxide dismutase (SOD) andCatalase levels were estimated on day 3 of life. All recruitedneonates were followed up till discharge or death.Results: Out of 250 neonates enrolled, 170 (68%) survived tillday 28 and BPD developed in 19 (11.2%) infants. The meangestation and birth weight were significantly lower in infants whodeveloped BPD. Chorioamnionitis (clinical 5.3% vs 1.9%,P=0.375; and histological 37.5% vs 16.7%, P<0.001), patentductus arteriosus (PDA) (52.6% vs 8.9%, P<0.001), median (IQR)sepsis episodes [2 (2,3) vs 1 (1,2), P<0.001], invasive ventilation(84.2% vs 11.3%, P<0.001), and duration of ventilation [56 (4) d vs4 (5) d, P=0.001] were significantly higher in infants with BPD.Serum MDA, SOD and Catalase levels were comparable betweenthe two groups.Conclusion: Chorioamnionitis, PDA and sepsis were significantlyassociated with BPD.

El rol de la hipertensión pulmonar en la displasia broncopulmonar / The role of pulmonary hypertension on bronchopulmonary dysplasia

Resumen Hace 50 años Northway describió la Displasia Broncopulmonar (DBP), en nacidos de pretérmino expuestos a ventilación mecánica. Desde entonces, ha aumentado la sobrevida de ellos; sin embar go, ha aparecido una "nueva DBP" y la incidencia de esta no ha disminuido. Una de las caracte rísticas de esta patología es la remodelación vascular anómala, que en su expresión más severa se conoce como Hipertensión Pulmonar (HP); con una incidencia de 17%, que es proporcional a la severidad de la DBP (33% en DBP severa); y como un factor de mortalidad (hasta un 48% mortali dad a 2 años con HP por DBP). Debido a esto resulta importante conocer los métodos diagnósticos y alternativas terapéuticas, tema que se discute en esta revisión. Considerando la alta mortalidad de la asociación HP-DBP, adquiere importancia una estrategia de tamizaje en la población de riesgo. El gold standard para el diagnóstico de HP es el cateterismo cardíaco, sin embargo, el ecocardio-grama transtorácico es una herramienta útil para el tamizaje y diagnóstico de HP en pacientes dis-plásicos, con mediciones cuantitativas y cambios cualitativos en la evaluación diagnóstica. A nivel sanguíneo el péptido natriurético tipo B (BNP), ha mostrado ser útil en el seguimiento; en cuanto a imágenes, la tomografía computarizada se utiliza en casos severos. En cuanto a las terapias, se han propuesto el óxido nítrico inhalado como vasodilatador pulmonar, los inhibidores de la fosfodies-terasas -sildenafil-, los antagonistas de la endotelina -bosentán- y los análogos de prostaciclinas -iloprost-. Aún no se cuenta con evidencia de alta calidad para su uso, dosis y duración del trata miento, pero hay variadas experiencias clínicas. Además, es relevante el cuidado interdisciplinario, destacando optimizar la nutrición. El desafío es lograr una prevención efectiva de la DBP y de sus complicaciones. Un protocolo de tamizaje de HP debe asociarse a una estratificación de riesgo y directrices de tratamiento.

Abstract 50 years ago, Northway described Broncopulmonary Dysplasia (BPD) in preterm infants exposed to mechanical ventilation. Since then, their survival has increased, nevertheless a "new BPD" has appeared and its incidence has not diminished. One of the characteristics of this pathology is the the abnormal vascular remodeling, which in its most severe expression is known as Pulmonary Hyper tension (PH); with an incidence of 17% in patients with BPD, which is proportional to the severity of the disease (33% in severe BPD), and as mortality factor (up to 48% 2-year mortality in PH-BPD). Thereby, it is important to know the diagnostic methods and therapeutic alternatives, topics discus sed in this review. Considering the high mortality in BPD associated PH, screening strategies in at risk population become important. The gold standard is cardiac catheterization; however, transtho-rathic echocardiography is a useful tool for the screening and diagnosis of PH in displasic patients, using cuantitive measures and cualitative changes in the evaluation. Seric type-B natriuretic peptide has shown to be useful for follow-up; regarding images, CT scan is used in severe cases. In terms of therapy; inhaled Nitric Oxide as a pulmonary vasodilator, phosphodiesterase inhibitors -sildenafil-, endotelin antagonists -bosentan-, and prostacyclin analogues -iloprost-, have been proposed. Their use, dosis and treatment lenght still lack support of high quality evidence, but diverse clinical expe riences have been described. Interdisciplinary care is also important, highlighting to optimize nu trition. Therefore, the challenge is to effectively prevent BPD and its complications. A PH screening protocol should be associated with risk stratification and treatment guidelines.

Telemonitorización del soporte ventilatorio domiciliario / Telemonitoring of domiciliary ventilatory support

More than 1,000 patients have been admitted to the pediatric ventilatory assistance program of the Chilean Ministry of Health. There are two subprograms depending on the complexity of patients. Since 2006 we have had the non-invasive home ventilatory assistance program (AVNI in Spanish) and the home invasive ventilatory assistance program (AVI in Spanish), derived from the AVNI program in 2008. Both provide coverage for patients under the age of 20, which complements the health network by delivering technology, home visits by professionals and respiratory supplies to ensure an adequate stay at the patients' homes with their families. It is in this context that remote telemonitoring emerges as an alternative to monitor the ventilatory therapy of these patients at home, which consists of remotely monitoring all ventilatory therapy; at present, there exist different tools to achieve this goal. The objective of this review is to describe the main telemonitoring systems available in Chile and their usefulness to check respiratory therapy in patients requiring home ventilatory support. As healthcare technology advances, the survival rate of patients requiring chronic ventilatory support increases; this situation, together with the high costs of hospital management for the health system and families, has brought about, in the last few years, the creation of home ventilatory support programs in Chile's public health system. In this context, telemonitoring emerges as a tool to optimize monitoring and timely adjustment of ventilatory parameters in patients receiving ventilatory support at home. It also seeks to reduce costs and increase safety

Actualmente han ingresado al programa de asistencia ventilatoria pediátrico del Ministerio de Salud de Chile más de 1000 pacientes. Existen dos sub programas dependiendo de la complejidad de los pacientes, es así como tenemos al programa de asistencia ventilatoria no invasiva domiciliaria (AVNI), que surgió durante el año 2006, y el programa de asistencia ventilatoria invasiva domiciliaria (AVI) que nace derivado del programa AVNI a partir del año 2008. Ambos entregan cobertura a pacientes menores de 20 años, complementando a la red de salud entregando la tecnología, visitas de profesionales en domicilio y una canasta de insumos respiratorios que aseguren una adecuada estancia en domicilio de los pacientes, junto a sus familias. Es en este contexto la telemonitorización a distancia surge como una alternativa para el seguimiento de la terapia ventilatoria de éstos pacientes en domicilio, la cual consiste en la monitorización en forma remota de toda la terapia ventilatoria , existiendo diferentes herramientas en la actualidad para llevala a cabo. El objetivo de esta revisión es describir los principales sistemas de telemonitorización disponibles en Chile, y su utilidad en la monitorización a distancia la terapia respiratoria de los pacientes que requieren soporte ventilatorio domiciliario. El avance de la tecnología sanitaría ha impactado en una mayor sobrevida de pacientes que requieren soporte ventilatorio crónico, el manejo hospitalario de estos pacientes tiene elevados costos para el sistema sanitario y las familias. En respuesta a esto durante los últimos años se han creado en el sistema público de salud de Chile programas de soporte ventilatorio domiciliario. En este contexto la telemonitorización surge como una herramienta que permite optimizar el seguimiento y el ajuste oportuno de los parámetros ventilatorios en los pacientes que reciben soporte ventiltorio domiciliario. Además busca disminuir los costos y aumentar la seguridad

Meta-analysis of the efficacy and safety of inhaled corticosteroids for preventing chronic lung disease in preterm infants / 临床儿科杂志

Objective To evaluate the efficacy and safety of inhaled corticosteroids for preventing chronic lung disease (CLD) in preterm infants. Methods PubMed, EMBASE, CENTRAL, the ISI Web of Knowledge databases, CBM, CNKI, VIP and Wanfang Data were searched for the period up to Oct. 2016. All randomized controlled trials (RCTs) about inhaled corticosteroids for preventing CLD in preterm infants were collected. The RCTs had been screened, data were extracted and assessed. The mata-analysis was performed by RevMan 5.3 software. Result A total of 12 RCTs were included (a total of 2051 preterm neonates). Compared with control group, in 28 day old group, the incidence of CLD was not significantly different between experimental and control groups (RR=0.87, 95%CI:0.74-1.03, P=0.11) and (RR=1.19, 95%CI:0.59-2.43, P=0.63) and no significant difference among subgroups budesonide (α), beclomethasone (β), fluticasone (γ) (RR=0.89, 95%CI:0.69-1.14, P=0.35), (RR=0.86, 95%CI:0.69-1.08, P=0.19) and (RR=0.91, 95%CI:0.60-1.38, P=0.19). In 36 wk postmenstrual age group,the incidence of CLD was decreased in experimental group and in subgroups inhalation (A), Intratracheal administration (B), α, γ (RR=0.70, 95%CI: 0.61-0.80, P<0.00001), (RR=0.74, 95%CI: 0.63-0.87, P=0.0003), (RR=0.57, 95%CI: 0.43-0.76, P=0.0002), (RR=0.67, 95%CI: 0.57-0.78, P<0.00001) and (RR=0.58, 95%CI: 0.36-0.94, P=0.03); but it is not significantly different in subgroup β(RR=0.98, 95%CI: 0.69-1.39, P=0.90); There was no difference in the motality in experimental and subgroups A ,B, α, β , γ (RR=1.07, 95%CI:0.86-1.33, P=0.55), (RR=1.24, 95%CI: 0.97-1.59, P=0.09), (RR=0.67, 95%CI: 0.43-1.03, P=0.07), (RR=1.04, 95%CI: 0.81-1.33, P=0.78), (RR=1.47, 95%CI: 0.79-2.74, P=0.22) and (RR=0.91, 95%CI: 0.47-1.74, P=0.77). No clinically significant adverse effects were observed during the study. Conclusions This updated review indicated that early administration of inhaled steroids to very low birth weight preterm neonates was effective in reducing the incidence of CLD. There was no statistically significant effect of inhaled steroids on motality, and there was no significant correlation between the mode of administration and the type of drug delivery, It is recommended to observe the 36 week gestational age as the outcome index. More and larger randomised placebo-controlled trials including long-term follow up are needed to establish the efficacy and safety of inhalation corticosteroids.

The evolvement of definition and nomenclature in bronchopulmonary dysplasia and advances in its treatment / 中国小儿急救医学

Bronchopulmonary dysplasia ( BPD) ,also called chronic lung disease ( CLD) ,is a com-mon respiratory disease of premature infants. It was first reported and named by Northway et al, carrying unique etiology,pathology and clinical features. BPD reported by Northway is referred as old or classic BPD. Manifestations and prognosis of premature infants with respiratory diseases have been improved significantly after evolutional changes by applying glucocorticoid and exogenous surfactant,as well as protective ventilator protocols after birth. Nowadays,incidents of severe BPD described by Northway are extremely low,whereas mild BPD,also called ‘new’ BPD,is much more common. Definition and nomenclature of BPD have been controversial since first being brought out in 1967. This article was focused on the definition and nomenclature and current advances in BPD treatment.

Clinical Characteristics of Patients with Bronchopulmonary Dysplasia Admitted to Pediatric Intensive Care Unit

PURPOSE: As the incidence of bronchopulmonary dysplasia (BPD) has increased, it is important to understand the clinical outcomes of BPD patients discharged from neonatal intensive care units (NICU). The purpose of our study was to describe the characteristics of BPD patients who are re-hospitalized in a pediatric intensive care unit (PICU) and to evaluate the prognostic outcome factors. METHODS: We retrospectively reviewed the medical records of BPD patients who were admitted to our PICU between May 2006 and November 2014. In total, we identified 101 cases which were divided into two groups, group 1, those who required intensive care for an acute illness or disease aggravation (n=62), and group 2, those who were admitted for post-operative care unrelated to having BPD as a control group (n=39). We subsequently compared the characteristics. RESULTS: Most patients in group 1 were aged less than 1 year, with weight below the 3rd percentile for age at the time of their PICU admission. The main cause for their admission was respiratory failure, requiring mechanical ventilation. When comparing the two groups, group 1 showed higher gestational age at birth, and a longer duration of mechanical ventilation, oxygen support, and NICU hospitalization than group 2. However, we failed to identify any factor significantly associated with the duration of the PICU stay, hospital stay, and mortality. Further large-scale, long-term follow-up studies will be necessary. CONCLUSION: As the majority of patients are admitted to PICU because of respiratory symptoms during their infantile period, careful follow-up with supportive care and prevention of respiratory infection are required.

La nueva displasia broncopulmonar desde el punto de vista de neumólogo pediatra / New bronchopulmonary dysplasia, from a pediatric pulmonologist´s perspective

Bronchopulmonary dysplasia (BPD) is the most prevalent chronic lung disease of prematurity. The so-called new BPD has replaced the classic BPD described by Northway, as a result of maternal use of corticosteroids, early surfactant and less aggressive mechanical ventilation and the survival of younger premature, born during the canalicular stage and that completed their alveolization outside the uterus. The new BPD is a less severe disease, but lung function is impaired in the long-term. An update of the new BPD, focused on the management after discharge from neonatology, from a pediatric pulmonologist perspective is presented.

La Displasia Broncopulmonar (DBP) es la enfermedad pulmonar crónica más prevalente del prematuro. La denominada nueva DBP ha reemplazado a la DBP clásica descripta por Northway, como consecuencia del uso de corticoides maternos, surfactante precoz, ventilación mecánica menos agresiva y la sobrevivencia de prematuros más pequeños, que nacen en etapa canalicular de su desarrollo pulmonar y completan su alveolización fuera del útero. La nueva DBP es una patología menos severa, pero con compromiso funcional respiratorio a largo plazo. A continuación se describe una actualización de la nueva DBP, enfocada en el manejo realizado luego del alta de neonatología, desde el punto de vista del Neumólogo Pediatra.

Neumonitis intersticial linfoidea en niños infectados por el virus de inmunodeficiencia humana-1 en zona de alta prevalencia de tuberculosis pulmonar / Lymphoid interstitial pneumonitis in children infected with type 1 human immunodefi ciency virus from areas with high pulmonary tuberculosis prevalence

Antecedentes : Poco se sabe sobre la neumonitis intersticial linfoidea (NIL) en niños con infección por el virus de inmunodeficiencia humana-1 (VIH-1) Objetivos: Describir las características clínicas y patológicas de NIL en niños infectados por VIH-1 en un centro de referencia para VIH pediátrico en Cali (Colombia). Métodos: Se llevó a cabo una descripción de serie de casos de NIL basados en revisión retrospectiva de historias clínicas de todos los casos de niños con enfermedad pulmonar crónica y LIP confirmada por biopsia entre los años 2001 y 2012. Resultados y conclusiones: Diez de 12 casos con NIL fueron confirmados por biopsia pulmonar. Se observó una respuesta clínica y de función respiratoria luego del tratamiento con prednisona, excepto en un caso que presentó tos persistente. No se encontraron casos de tuberculosis pulmonar (TP) en nuestra serie y el papel de la biopsia pulmonar fue crítico para alcanzar un diagnóstico preciso.

Background: Little is known about Lymphoid Interstitial Pneumonitis (LIP) in children with HIV infection. Aims: To describe the clinical and pathological characteristics of LIP in infected children in a referral center for pediatric HIV in Cali (Colombia). Methods: Case series based on retrospective analysis of clinical charts among HIV-infected children with chronic lung disease and lung-biopsy proven LIP between the years 2001 and 2012. Results and conclusions: 10 of 12 cases of LIP were confirmed by lung biopsy. Significant clinical and respiratory functional improvement was obtained in all cases after prednisone therapy, excepting one child who presented persistent cough. No case of pulmonary TB was detected in our cohort. Lung biopsy was critical to obtain an accurate diagnosis.

Epidemiology, Clinical Characteristics, and Pathophysiology of Bronchopulmonary Dysplasia

Recent advance in perinatal care resulted in improved survival of very low birth weight (VLBW) infants. However, bronchopulmonary dysplasia (BPD) is still one of major complications of VLBW infants. Four decades have passed since BPD was described for the first time in 1967. Since then epidemiology, clinical characteristics, and pathophysiology of BPD have changed markedly. In this article, We reviewed the recent progress in research for epidemiology, clinical characteristics, and pathophysiology of BPD.

Bases fisiopatológicas del entrenamiento muscular en pacientes con enfermedad pulmonar obstructiva crónica / Pathophysiological bases of muscular training in patients with chronic obstructive pulmonary disease

Dyspnea and decreased exercise capacity are the main factors that limit the daily living activities in patients with chronic respiratory diseases. The cardinal symptoms limiting exercise capacity in most patients with chronic obstructive pulmonary disease (COPD) are dyspnea and fatigue, which could be caused by alveolar ventilation and gas exchange disturbances, skeletal muscle dysfunction and/or cardiovascular failure. Anxiety, lack of motivation and depression were also associated with reduced exercise capacity, probably affecting the perception of symptoms. The relationship between psychological status and mood disorders in patients with COPD and exercise tolerance is complex and not yet fully understood. The origin of the exercise capacity limitation in COPD patients is multifactorial, so the separation of the variables involved for academic purposes is not always feasible. The pathogenic mechanisms may interact in complex ways, as an example, muscle deconditioning and hypoxemia can increase alveolar ventilation causing exercise limitation. Therefore, physical training and supplemental oxygen can reduce ventilatory limitation during exercise without changing lung function and maximum ventilatory capacity. The analysis of these factors could potentially identify reversible conditions that can improve the exercise performance and quality of life ofpatients with COPD, such as hypoxemia, bronchospasm, heart failure, arrhythmias, musculoskeletal dysfunction and myocardial ischemia. This review examines the principal mechanisms contributing to physical activity limitation in patients with COPD: alveolar ventilation and gas exchange abnormalities, cardiovascular and musculoskeletal system dysfunction, and respiratory muscles dysfunction.

La disnea y la disminución de la capacidad de realizar ejercicio son los principales factores que limitan las actividades de la vida diaria en pacientes con enfermedades respiratorias crónicas. Los síntomas cardinales que limitan la capacidad de ejercicio en la mayoría de los pacientes con enfermedad pulmonar obstructiva crónica (EPOC) son la disnea y/o fatigabilidad, los cuales pueden ser ocasionados por trastornos de la ventilación alveolar e intercambio gaseoso, disfunción de los músculos esqueléticos y/o falla cardiovascular. La ansiedad, falta de motivación y depresión también han sido asociadas a una menor capacidad de realizar ejercicio, probablemente afectando la percepción de los síntomas. La relación entre el estado psicológico y los trastornos del ánimo en pacientes con EPOC y la tolerancia al ejercicio es compleja y aún no ha sido completamente dilucidada. El origen de la limitación de la capacidad de ejercicio en pacientes con EPOC es multifactorial, por lo cual la separación de las variables involucradas con fines académicos no siempre es factible realizarlo en los pacientes. Los mecanismos patogénicos pueden relacionarse en forma compleja, a modo de ejemplo, el desacondicionamiento físico y la hipoxemia pueden contribuir a aumentar la ventilación alveolar ocasionando limitación del ejercicio de causa ventilatoria. Por lo tanto, el entrenamiento físico y el suplemento de oxígeno pueden reducir la limitación ventilatoria durante el ejercicio sin modificar la función pulmonar o la capacidad ventilatoria máxima. El análisis de los factores limitantes de la capacidad de ejercicio permite identificar trastornos potencialmente reversibles que pueden mejorar la calidad de vida de los enfermos, tales como la hipoxemia, broncoespasmo, insuficiencia cardiaca, arritmias, disfunción musculoesquelética y/o isquemia miocárdica. En esta revisión se examinan los principales mecanismos que contribuyen a la limitación de la actividad física en pacientes con EPOC:...

Progress on vitamin A for newborn respiratory distress / 国际儿科学杂志

Chronic lung disease (CLD) of prematurity is the major cause of long-term disability of extremely low birth weight ( ELBW ) premature infants, and it is the most cost consumptive disease in neonatal intensive care unit graduates.Vitamin A plays an important role in the development of premature lung. Nevertheless, premature infants are prone to vitamin A deficiency.Oral supplementation of vitamin A does not alter the incidence of CLD in ELBW infants.Intramuscular administration of vitamin A reduced the incidence of CLD.The treatment is considered painful and this way is not routinely practiced.Vitamin A is systemically bioavailable after intratracheal administration with surfactant in an animal model of newborn respiratory distress.

Bronquiectasis en Pediatría

La Bronquiectasia es una enfermedad poco frecuente en pediatría y representa el estado final de una variedad de procesos patológicos. El objetivo de este trabajo es llamar la atención en hace el diagnóstico temprano y brindar un tratamiento temprano y adecuado de las enfermedades pulmonares agudas y crónicas en pediatría para tratar de evitar las complicaciones como las Bronquiectasias. Materiales y métodos: Se realizó este estudio prospectiva durante el periodo comprendido entre el 1 de enero 2006 y el 30 de abril de 2010 en el Hospital de Especialidades Pediátrica. Se incluyeron en este trabajo todos los pacientes mayores de 1 mes hasta los 15 años que durante el periodo de estudio se le realizó el diagnóstico de bronquiectasias de forma ambulatoria u hospitalaria. Se registraron y analizaron las siguientes informaciones como la edad y sexo, diagnóstico de la enfermedad de base, edad de presentación de las bronquiectasias, características de las imágenes radiográficas de las bronquiectasias, , análisis espirométricos, resolución de las bronquiectasias, características de las bronquiectasias, y la mortalidad. Resultados: Un total de 7 pacientes se le realizó el diagnóstico de bronquiectasias durante el periodo de estudio. En relación a la distribución de los pacientes por edad podemos observar que el 57.1% ( 4 pacientes) se presentaron a una edad de 10-15 años. Con respecto al sexo hubo predilección por el sexo femenino en el 57.1% ( 4 pacientes). El 86% ( 6 pacientes) cursaban con una enfermedad de base. La edad de presentación de las bronquiectasias observada más frecuentes fue a la edad de 5-15 años en el 57% de los casos. En relación a las imágenes de las bronquiectasias fueron más frecuentes las cilíndricas y focales en el 100% de los pacientes y además 2 de los cuales presentaron imágenes quística y varicosas. En 4 de nuestros casos se le pudo realizar una espirometría siendo informada como limitación ventilatoria restrictiva. Conclusiones: Aunque se considera que las bronquiectasias son poco frecuentes en la población pediátrica, en nuestro medio como en otros países en vías de desarrollo, las infecciones respiratorias agudas bajas son una de las principales causas de morbi-mortalidad en los niños, siendo un importante factor de riesgo para el desarrollo de las bronquiectasias.

The bronchiectasis is a slightly frequent disease in pediatrics and represents the final condition of a variety of pathological processes. The aim of this work is to call the attention in doing the early diagnosis and offering an early and suitable treatment of the pulmonary sharp and chronic diseases in pediatrics to try to avoid the complications as the bronchiectasis. Materials and methods: This market study was realized during the period understood between 1 January, 2006 and April 30, 2010 in the Hospital de Especialidades Pediátricas. There were included in this work all the major patients of 1 month up to 15 years that during the period of study, the diagnosis was realized of bronchiectasis of ambulatory or hospitable form. They registered and analyzed the following information like the age and sex, diagnosis of the base disease, age of presentation of the bronchiectasis, characteristics of the radiographic images of the bronchiectasis, and the mortality. Results : A total of 7 patients carried out the diagnosis of bronchiectasis during the period of study. In relation to the distribution of the patients for age we can observe that 57.1% ( 4 patients) appeared to an age of 10- 15 years. With regard to the sex there was predilection for the feminine sex in 57.1% (4 patients). 86%( 6 patients) was dealing with a base disease. Conclusions: Though it thinks that the bronchiectasis are slightly frequent in the pediatric population, in our way as in other developing countries, the respiratory sharp low infections are one of the principal reasons of morbid-mortality in the children, being an important factor of risk for the development of the bronchiectasis.

Alveolar damage and the alveolar epithelial cell change in neonatal rats with chronic lung disease induced by hyperoxia / 中国小儿急救医学

Objective To explore the changes of alveolar morphology and alveolar epithelial cells in rats with hyperoxia-induced chronic lung diseases (CLD). Methods CLD model in neonatal rats was established by inhalation of high concentration oxygen(85%～90% ). Eighty neonatal rats were randomly exposed to hyperoxia (model group) and to room air (control group) (n =40 each). Radical alveolar counts and the alveolar septum thickness were used to evaluate alveolar development. The site and intensity of expression of SPC,AQP5 protein were detected by immunohistochemical staining,the dynamic expression of SPC mRNA,AQP5mRNA was detected by RT-PCR on day 1,3,7,14 and 21 after exposure. Results There were no significant differences about alveolar wall thickness and RAC between experimental groups and control group on day 1～3 ( P > 0. 05 ). But there was significant difference between the model group and the control groups on day 7 and 14 (P <0. 01 ). For model group,alveolar septum thickness peaked on day 21, the difference was significant compared with control group ( 10. 62±5.01 vs 3.62±0. 88, P < 0. 001 ), but RAC decreased to the lowest level, the difference was significant compared with control group ( 3.57±1.24 vs 10. 47±0. 88,P <0. 001 ). The expression of SPC decreased on day 3 manifestedly but increased on day 7 and the levels of SPC were higher than that in the control group. Experimental group showed gradual decrease in AQP5 expression as the lung impairment devastated. Conclusion Alveolar development was delayed and alveolar epithelial cell (AEC) was damaged in the neonatal CLD rats. The changes of SPC,AQP5 expression suggested AECI was severely damaged and failed in full recovery, meanwhile the quantity of AEC Ⅱ was increased but the ability of its differentiation and transformation was decreased.

Mitogen activated protein kinase and chronic lung disease in preterm infants / 国际儿科学杂志

Chronic lung disease is a very common complication caused by inhaled hyperoxia, mechanical ventilation and pulmonary infection in preterm infants. It shows early inflammation and late alveoli fusion with mesenchymal fibroblast proliferation. Mitogen activated protein kinase is a very important signal transduction pathway in eukaryotic cells.It plays an important role in the cell inflammation, proliferation, differentiation, survival and apoptosis, which may contributes to the chronic lung disease.